Home-based Intervention to Test and Start

NCT03757104 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4667

Last updated 2018-11-28

No results posted yet for this study

Summary

This study aims to establish the causal impact of two interventions - micro-incentives and a male-sensitive HIV- specific decision support app - on population-level HIV viral load and HIV-related mortality in men, as well as on population-based HIV incidence in young women.

Conditions

  • HIV
  • HIV Testing
  • Linkage to Care

Interventions

BEHAVIORAL

micro-incentive

Residents in these communities are eligible to receive a R50 food voucher conditional on undergoing a home-based HIV test. If diagnosed with HIV, residents are eligible to receive a second R50 food voucher when they link to care within 6 weeks of the HIV test

BEHAVIORAL

EPIC-HIV

Men in these communities are eligible to receive a tablet-based male-sensitive HIV decision support app (EPIC-HIV 1)to encourage them to test for HIV at home. If diagnosed with HIV and do not link to care within a month of HIV test, they become eligible to receive a tablet-based male HIV specific decision support app (EPIC-HIV 2) to encourage them to link to HIV care.

BEHAVIORAL

micro-incentive and EPIC-HIV

micro-incentives: Residents in these communities are eligible to receive a R50 food voucher conditional on undergoing a home-based HIV test. If diagnosed with HIV, residents are eligible to receive a second R50 food voucher when they link to care within 6 weeks of the HIV test. EPIC-HIV 1: Men in these communities are eligible to receive a tablet-based male-sensitive HIV specific decision support app (EPIC-HIV 1) to encourage them to test for HIV at home. If diagnosed with HIV and do not link to care within a month of HIV test, they become eligible to receive a tablet-based male HIV specific decision support app (EPIC-HIV 2) to encourage them to link to HIV care.

Sponsors & Collaborators

  • Heidelberg University

    collaborator OTHER
  • University College, London

    collaborator OTHER
  • London School of Hygiene and Tropical Medicine

    collaborator OTHER
  • University of Glasgow

    collaborator OTHER
  • University of Southampton

    collaborator OTHER
  • Africa Health Research Institute

    lead OTHER

Principal Investigators

  • Frank Tanser, PhD · Africa Health Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-06
Primary Completion
2021-12-31
Completion
2022-12-31

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03757104 on ClinicalTrials.gov